Canadian IPOs All But Vanished in 2022: Here’s How 3 New Listings Did

A $9.2 billion Canadian IPO market in 2021 slumped to record lows in 2022. Two IPOs produced market-beating returns. Here how Bausch + Lomb Corp stock and others performed.

| More on:

Initial public offerings (IPOs) are spectacular events in the Canadian stock market. They present investors with more opportunities to choose from, provide more chances of hitting jackpot-type returns, and offer more options to improve portfolio diversification. However, following the record-breaking year 2021, when Canadian IPOs raised $10.2 billion from the public market, the IPO market abruptly cooled off to record lows in 2022.

About 77 new companies graced Canadian exchanges in 2021. They raised a record $9.2 billion. The number excludes Special Purpose Acquisition Companies (SPACs) and capital pool funds. The market turned south in 2022. The number of new Canadian IPOs declined to 42 companies in 2022, raising a paltry $1.3 billion.

Why Canadian IPOs vanished in 2022

The Canadian and global investment market environment abruptly changed between 2021 and 2022.

Investor spirits were high and optimism reigned in the markets in 2021. Easy money flooded the capital markets, as interest rates touched record lows. The TSX soared by 21% for the year. It was a great time for companies to raise new capital in the market by going public. It was the best time for early investors to sell stocks and exit long-held private investments to new shareholders through IPOs.

Moods changed in 2022. Investors freaked out, as “transitory” inflation threatened to stay. Interest rates rose at a record pace, and markets tumbled. Growth stocks with frothy valuations and weak fundamentals got clobbered.

Very few investors, IPO sponsors, founders, and company executives were willing to bring new companies onto exchanges when stock prices were coming down. Not only would their compensation be too low, but the risk of losing money was also just too high.

However, not all 2022 IPOs lost investors’ money. Here’s how the three largest Canadian news listings performed during their first calendar year trading on the public stock market.

Kiwetinohk Energy

Natural gas producer and fast-growing renewable energy company Kiwetinohk Energy (TSX:KEC) was listed on the TSX and started trading on January 14, 2022. The company chose a brilliant time to go public. Rapid production growth and soaring oil and natural gas prices gave new IPO investors great reasons to invest in the ambitious natural gas and green energy firm.

At the time of going public, management guided for 2022 production of 13,000-15,000 barrels of oil equivalent per day (boe/d). Full-year 2022 production averaged 17,900 boe/d. The company overdelivered on its production promises, and surging oil and natural gas prices amplified the financial impact.

Revenue and funds flow exceeded prior market estimates. KEC stock price closed 16.6% higher for 2022.

Ivanhoe Electric

Technology and mineral exploration company Ivanhoe Electric (TSX:IE) went public in a private equity-backed, dual-listed IPO in June 2022 that raised US$169 million. Shares also trade on the NYSE.

Ivanhoe Electric’s most attractive asset is its disruptive Typhoon, a geophysical survey technology obtained from its parent company I-Pulse. The Typhoon technology can cost effectively detect copper, gold, silver, and nickel, water, and oil at depths deeper than other conventional technologies’ given ranges, or where a cover hides deposits, and across vast tracts of land.

The company uses its survey technology exclusively, however, a recent US$126.4 million investment deal with Saudi Arabia’s mining giant Ma’aden will extend Typhoon access to a third party for the first time.

Ivanhoe Electric stock rose 16.9% during 2022. IE stock is up 26.1% since its IPO and trades 8.4% higher so far this year.

Bausch + Lomb

Bausch + Lomb (TSX:BLCO) is an $8.1 billion company that spun off from parent company Bausch Health in a dual-listed IPO on the TSX and the New York Stock Exchange in May 2022. The company is a global eye healthcare giant, with significant clout in the populous markets of India and China.

The parent company Bausch Health retains a controlling stake in the spin-off and donated its Chief Executive Officer Joseph C. Papa to the newly listed company. Papa is set to leave Bausch + Lomb in March this year.

Reported net earnings significantly declined in 2022, even as revenue remained stable. Operating costs and interest costs have increased as the company became a standalone business weaned from its parent.

BLCO stock lost 17.9% of its value post-IPO in 2022. That said, shares are up 7.5% year to date.

Fool contributor Brian Paradza has no positions in any of the stocks mentioned. The Motley Fool has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy.

More on Investing

woman checks off all the boxes
Dividend Stocks

5 CRA Red Flags to Watch in Retirement Tax Returns

A few common retirement-return mistakes can trigger CRA follow-up, and most are avoidable with a quick pre-filing checklist.

Read more »

Business success of growth metaverse finance and investment profit graph concept or development analysis progress chart on financial market achievement strategy background with increase hand diagram
Bank Stocks

1 Canadian Stock That Comes Close to Perfect as a Long-Term Hold

Fairfax Financial (TSX:FFH) combines a resilient insurance business with disciplined investing and smart capital allocation, making it one of the…

Read more »

A worker overlooks an oil refinery plant.
Dividend Stocks

An Ideal TFSA Stock With a Steady 4.4% Yield

Here's why this defensive growth stock offering a yield of roughly 4.4% today is such an ideal investment for a…

Read more »

Women's fashion boutique Aritzia is a top stock to buy in September 2022.
Tech Stocks

What Are the Best High-Growth Canadian Stocks to Buy Now?

Three Canadian growth stocks look compelling, but they’re priced for success, so gradual buying and position sizing matter.

Read more »

Dividend Stocks

3 Undervalued Canadian Dividend Stocks to Buy Now and Hold for Years

Three Canadian value ideas offer a mix of growth, income, and a real-asset discount, without relying on a “too-good-to-be-true” yield.

Read more »

House models and one with REIT real estate investment trust.
Dividend Stocks

1 Dividend Stock I’d Feel Good About Owning for the Next 7 Years

Choice Properties REIT offers a reliable 4.8% yield backed by Loblaw leases. Here is why this Canadian dividend stock is…

Read more »

holding coins in hand for the future
Dividend Stocks

My 2 Favourite Stocks for Monthly Passive Income

Unlock the potential of monthly dividends with Canadian stocks, focusing on REITs and royalty companies for consistent cash flow.

Read more »

hand stacks coins
Dividend Stocks

3 Dividend Stocks Yielding +4% Canadians Can Own Even When Growth Falls Out of Favour

These three dividend stocks are worth considering for passive income and long-term growth, particularly on market dips.

Read more »